Suchergebnisse - "Aliter, Kholoud F"

PubPharm (12)

1

Substituted 4H-3,1-benzoxazine-4-one Derivatives as Inhibitors of Cathepsin G

enthalten in: Medicinal chemistry (Shariqah (United Arab Emirates)) | 2024

von Aliter, K. | Al-Horani, R.

2

Future is Brighter : New Potential Paradigm-Shifting Medications and Regimens for Diabetes and Obesity

enthalten in: Current diabetes reviews | 2024

von Al-Horani, R. | Aliter, K. | Aliter, H.

3

Triple Action of Lignosulfonic Acid Sodium : Anti-protease, Antioxidant, and Anti-inflammatory Effects of a Polymeric Heparin Mimetic

enthalten in: Medicinal chemistry (Shariqah (United Arab Emirates)) | 2024

von Al-Horani, R. | Aliter, K.

4

Sulphated penta-galloyl glucopyranoside (SPGG) is glycosaminoglycan mimetic allosteric inhibitor of cathepsin G

enthalten in: RPS pharmacy and pharmacology reports | 2023

von Al-Horani, R. | Afosah, D. | Kar, S. | +2

5

Sulfonated Nonsaccharide Heparin Mimetics Are Potent and Noncompetitive Inhibitors of Human Neutrophil Elastase

enthalten in: ACS omega | 2021

von Al-Horani, R. | Aliter, K. | Kar, S. | +1

6

Thrombin Inhibition by Argatroban : Potential Therapeutic Benefits in COVID-19

enthalten in: Cardiovascular drugs and therapy | 2021

von Aliter, K. | Al-Horani, R.

7

Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients

enthalten in: Current pharmaceutical design | 2021

von Aliter, K. | Al-Horani, R.

8

Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients

enthalten in: Current pharmaceutical design | 2021

von Aliter, K. | Al-Horani, R.

9

Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19

enthalten in: Cardiovascular drugs and therapy | 2020

von Aliter, K. | Al-Horani, R.

10

Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19

enthalten in: Cardiovascular drugs and therapy | 2020

von Aliter, K. | Al-Horani, R.